abusesaffiliationarrow-downarrow-leftarrow-rightarrow-upattack-typeburgerchevron-downchevron-leftchevron-rightchevron-upClock iconclosedeletedevelopment-povertydiscriminationdollardownloademailenvironmentexternal-linkfacebookfiltergenderglobegroupshealthC4067174-3DD9-4B9E-AD64-284FDAAE6338@1xinformation-outlineinformationinstagraminvestment-trade-globalisationissueslabourlanguagesShapeCombined Shapeline, chart, up, arrow, graphLinkedInlocationmap-pinminusnewsorganisationotheroverviewpluspreviewArtboard 185profilerefreshIconnewssearchsecurityPathStock downStock steadyStock uptagticktooltiptwitteruniversalityweb

Diese Seite ist nicht auf Deutsch verfügbar und wird angezeigt auf English

Artikel

24 Mai 2019

Autor:
Amnesty International; Access Now; Committee to Protect Journalists; Digital Rights Foundation; Human Rights Watch; Privacy International; R3D: Red en Defensa de los Derechos Digitales; Reporters Without Borders; Robert L. Bernstein Institute for Human Rights, NYU School of Law and Global Justice Clinic, NYU School of Law

NGO coalition statement in response to Novalpina Capital’s letter of 15 May 2019

Statement in response to Novalpina Capital’s letter of 15 May 2019

To: Stephen Peel
Cc: Stefan Kowski, Bastian Lueken, Shalev Hulio, Vivek Krishnamurthy, Foley Hoag LLP

We acknowledge receipt of Novalpina Capital’s letter of 15 May 2019. A number of significant issues remain insufficiently addressed by Novalpina Capital’s letters and overall approach to engagement with civil society.

As illustrated in the May 15 letter in particular, there appears to be a fundamental conflict between Novalpina Capital’s assertions of broad national secrecy requirements and constraints on disclosure under Israeli law, and its purported commitment to greater transparency and human rights impact assessments regarding NSO Group. It is unclear whether Novalpina Capital will be able to release information that is essential to determining whether it is preventing, mitigating, and remedying adverse human rights impacts, as envisioned by the UN Guiding Principles on Business and Human Rights.

The undersigned organizations, individually or collectively, will continue to closely monitor and advocate regarding the activities and human rights impacts of Novalpina Capital and NSO Group.

Signed,

Amnesty International
Access Now
Committee to Protect Journalists
Digital Rights Foundation
Human Rights Watch
Privacy International
R3D: Red en Defensa de los Derechos Digitales
Reporters Without Borders
Robert L. Bernstein Institute for Human Rights, NYU School of Law and Global Justice Clinic, NYU School of Law*

*Communications from NYU clinics and institutes do not purport to reflect the school's institutional views, if any.

Zeitleiste

Informationen zum Datenschutz

Diese Website verwendet Cookies und andere Web-Speichertechnologien. Sie können Ihre Datenschutzeinstellungen unten festlegen. Die Änderungen werden sofort wirksam.

Weitere Informationen über unsere Nutzung von Webspeicherung finden Sie in unserer Richtlinie zur Datennutzung und Cookies

Strictly necessary storage

ON
OFF

Necessary storage enables core site functionality. This site cannot function without it, so it can only be disabled by changing settings in your browser.

Analytics-Cookie

ON
OFF

When you access our website we use Google Analytics to collect information on your visit. Accepting this cookie will allow us to understand more details about your journey, and improve how we surface information. All analytics information is anonymous and we do not use it to identify you. Google provides a Google Analytics opt-out add on for all popular browsers.

Promotional cookies

ON
OFF

We share news and updates on business and human rights through third party platforms, including social media and search engines. These cookies help us to understand the performance of these promotions.

Ihre Privatsphäre-Einstellungen für diese Website

Diese Website verwendet Cookies und andere Web-Speichertechnologien, um Ihre Erfahrung über die notwendigen Kernfunktionen hinaus zu verbessern.